LOXL1 and renal cell carcinoma: Besides, such phenomenon was further testified by enhanced E-cadherin level and reduced levels of N-cadherin and MMP2 in these two RCC cells facing LOXL1-AS1 deficiency (Supplementary Figure S1B).